BioLife Solutions Inc (BLFS)

Debt-to-equity ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	18,311	20,937	23,572	23,692	23,793	24,207	6,188	6,313	6,353	6,122	5,019	916	655	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	337,663	332,017	352,128	358,107	364,188	405,120	409,544	476,075	478,047	489,259	452,281	208,777	204,429	186,851	105,843	67,709	43,321	35,191	2,072	-3,740
Debt-to-equity ratio		0.05	0.06	0.07	0.07	0.07	0.06	0.02	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $18,311K ÷ $337,663K
= 0.05

BioLife Solutions Inc's debt-to-equity ratio has been relatively stable over the quarters, with values ranging from 0.05 to 0.07. This indicates that the company has a conservative capital structure, with a lower reliance on debt financing compared to equity. The decreasing trend in the debt-to-equity ratio over the quarters suggests that the company is gradually reducing its debt levels relative to equity, which can be viewed positively as it signifies improved financial stability and lower financial risk. The debt-to-equity ratio reaching 0.00 in recent quarters indicates that the company might be debt-free or carrying a minimal amount of debt in relation to its equity, reflecting a strong financial position in the short term.